Patent ID: 7960118
Filing Date: 2011-06-14
Classification: A61K,A61P,C12Q,G01N

Abstract:
1. A method for determining the prognosis of a patient having a tumor, comprising determining in a sample of said tumor the presence or absence of a G719A, E746K, S768I, L858P, or E746-R748 del, ins epidermal growth factor receptor (EGFR) protein mutation or a nucleic acid encoding a G719A, E746K, S768I, L858P, or E746-R748 del, EGFR protein mutation, whereby the presence of said EGFR protein mutation or said gene encoding said EGFR protein mutation indicates better prognosis compared to the absence of said EGFR protein mutation or said nucleic acid encoding said EGFR protein mutation.